GlassScriptPhysician profile
Ibrahim M Hegab
NPI 1982622825
$4,383.09
in general payments reported to CMS, 2019-2025
40 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,407 · 2020: $570 · 2021: $2,039 · 2022: $66.63 · 2023: $56.46 · 2024: $40.63 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $459.62 | 2019-2025 | |
| Abbvie INC. | $381.15 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $367.21 | 2021 | |
| Biogen, INC. | $317.00 | 2019-2021 | |
| Genzyme Corporation | $300.15 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $264.34 | 2021 | |
| Emd Serono, INC. | $224.89 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $200.16 | 2019-2021 | |
| Amgen INC. | $165.23 | 2019-2021 | |
| Livanova USA, INC. | $149.93 | 2019-2021 | |
| Ucb, INC. | $140.59 | 2021 | |
| Supernus Pharmaceuticals, INC. | $132.21 | 2019-2022 | |
| Adamas Pharmaceuticals, INC. | $123.42 | 2019 | |
| Allergan, INC. | $117.12 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $112.32 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $98.04 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $94.61 | 2021 | |
| Eisai INC. | $75.83 | 2019-2021 | |
| Genentech USA, INC. | $72.67 | 2019-2021 | |
| Greenwich Biosciences, INC. | $65.84 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $55.06 | 2019 | |
| Csl Behring | $47.41 | 2021 | |
| Pfizer INC. | $43.97 | 2025 | |
| Ge Healthcare | $40.27 | 2019-2023 | |
| Amneal Pharmaceuticals LLC | $39.85 | 2019-2021 | |
| Lundbeck LLC | $35.59 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $32.69 | 2021 | |
| Avanir Pharmaceuticals, INC. | $27.12 | 2019-2021 | |
| Inspire Medical Systems, INC. | $24.74 | 2024 | Inspire |
| Argenx US, INC. | $24.59 | 2025 | Vyvgart Hytrulo |
| Vanda Pharmaceuticals INC. | $18.18 | 2020 | |
| Mallinckrodt Enterprises LLC | $16.97 | 2019 | |
| Sk Life Science, INC. | $16.56 | 2021 | |
| Banner Life Sciences, LLC | $16.03 | 2021 | |
| Grifols USA, LLC | $14.65 | 2021 | |
| Mdd US Operations, LLC | $14.47 | 2019 | |
| Celgene Corporation | $14.26 | 2021 | |
| Grt US Holding, INC. | $14.00 | 2021 | |
| Assertio Therapeutics, INC. | $12.29 | 2020 | |
| Medtronic Vascular, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ibrahim Hegab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.